MRNA

Moderna (MRNA) Market Capitalization Overview
Market Cap: $103.16B as of Nov 4, 2026
$103.16B
$27.30B (35.98%)past month
As of Nov 4, 2026, Moderna (MRNA) has a market capitalization of $103.16B. Over the past 30 days, its market cap has increased by 16.88%, while in the last 12 months, it has increased by 795.23%.
Market capitalization represents the total value of Moderna as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Moderna (MRNA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Moderna (MRNA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Moderna as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Moderna (MRNA) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Moderna (MRNA) helps investors assess the company's size and compare it with competitors for better investment decisions.
Moderna (MRNA) Market Cap & Key Trends
See Moderna’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Moderna (MRNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Moderna (MRNA) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Nov 2, 2026 | $88.17B | +16.88% |
| Oct 1, 2026 | $75.44B | +22.47% |
| Sep 1, 2026 | $61.60B | +181.51% |
| Aug 3, 2026 | $21.88B | -23.94% |
| Jul 1, 2026 | $28.77B | +57.40% |
| Jun 1, 2026 | $18.28B | +1.57% |
| May 1, 2026 | $17.99B | -8.94% |
| Apr 1, 2026 | $19.76B | -5.33% |
| Mar 2, 2026 | $20.88B | +25.53% |
| Feb 2, 2026 | $16.63B | +37.88% |
| Jan 2, 2026 | $12.06B | +27.73% |
Moderna (MRNA) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $103.16B | +795.23% |
| 2025 | $11.53B | -27.99% |
| 2024 | $16.01B | -57.80% |
| 2023 | $37.92B | -45.05% |
| 2022 | $69.01B | -32.99% |
| 2021 | $102.98B | — |
FAQs About Moderna (MRNA) Market Cap
As of Nov 4, 2026, the market capitalization of Moderna (MRNA) is $103.16B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Moderna’s market capitalization has increased by 35.98%, changing from $75.86B to $103.16B as of Nov 4, 2026.
In the last 3 months, Moderna’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Moderna’s market capitalization decreased from $16.01B in January to $11.53B in December, reflecting a -27.99% change.
In the past five years, Moderna (MRNA) has had a compound annual growth rate (CAGR) of -35.47% in market capitalization. This means its market cap has shrunk at an average rate of -35.47% per year.
Moderna (MRNA) Market Cap & Key Trends
See Moderna’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Moderna (MRNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.